Editorial board

Editor-in-Chief

Attila T Lorincz, Queen Mary University of London, UK

Associate Editors

William C S Cho, Queen Elizabeth Hospital, Hong Kong

Samir Hanash, Fred Hutchinson Cancer Research Center, WA, USA

George Poste, Arizona State University, AZ, USA

Jeffrey S Ross, Albany Medical College, NY, USA

Editorial Board Members

Borry P, Katholieke Universiteit Leuven, Leuven, Belgium

Calin GA, University of Texas: MD Anderson Cancer Center, TX, USA

Chan KCA, The Chinese University of Hong Kong, Hong Kong SAR, China

Cheng L, Brown University, RI, USA

Cimadamore A, Polytechnic University of the Marche Region, Italy

Goel A, City of Hope Comprehensive Cancer Center, CA, USA

Hardiman G, Queen's University Belfast, NI, UK

Klein R, Cleveland Clinic, OH, USA

Kost G, UC Davis, CA, USA

Liotta LA, George Mason University, VA, USA

Lo D, The Chinese University of Hong Kong, Hong Kong, China

McCarthy MW, Cornell University, NY, USA

Michael JS, Christian Medical College, Vellore, India

Montironi R, Polytechnic University of the Marche Region, Ancona, Italy

Ogino S, Dana-Farber Cancer Institute, MA, USA

Povoski SP, Ohio State University, OH, USA

Pritzker KH, RNA Diagnostics Inc., Toronto, Canada

Rolain JM, Aix-Marseille Université, Marseille, France

Salto-Tellez M, Queen’s University Belfast, Belfast, UK

Schildgen O, Hospital of the Private University, Cologne, Germany

Schittenhelm J, Eberhard Karls University Tuebingen, Tuebingen, Germany

Traeger-Synodinos J, National and Kapodistrian University of Athens, Athens, Greece

Trøst Jørgensen J, Dx-Rx Institute, Fredensborg, Denmark

Van Der Pol B, University of Alabama at Birmingham School of Medicine, AL, USA

Wojdacz TK, University of Aarhus, Aarhus, Denmark